An active ingredient (AI) is a physiologically active ingredient in a medicine or insecticide. In medicine, the phrases Active Pharmaceutical ingredient (API) and bulk active are used interchangeably, while the term active material may be applied to natural goods. The active component. An active ingredient (AI) is a physiologically active ingredient in a medicine or insecticide. In medicine, the phrases active pharmaceutical ingredient (API) and bulk active are used interchangeably, while the term active material may be applied to natural goods. A pharmaceutical dosage form contains the active pharmaceutical component, which is the medicinal ingredient itself, as well as excipients, which are the contents of the tablet, the liquid in which the active agent is suspended, or other pharmaceutically inert material. Drugs are usually chosen for their active ingredients. Excipients are carefully chosen during formulation development to ensure that the active component reaches the desired area in the body at the proper rate and extent. Patients frequently struggle to identify the active elements in their medications and are frequently uninformed of the concept of an active ingredient. Many medications' active ingredients can interact with one another, resulting in significant or life-threatening outcomes.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand